NFE2L2 and esophageal squamous cell carcinoma: Mutations in the NFE2L2 gene that were significantly associated with poor prognosis were identified, and three ESCC subtypes (NFE2L2‐mutated, RTK‐RAS‐MYC‐amplified, and double‐negative) were proposed